Causaly amplifies human cognitive abilities to expand the boundaries of discovery towards making the best decisions in Biomedicine.
To achieve this, we are teaching computers to read all knowledge ever published and develop an interface that allows humans to answer questions they can’t ask anywhere else.
Location: United Kingdom, England, London
Employees: 51-200
Total raised: $83M
Founded date: 2018
Investors 3
Date | Name | Website |
08.06.2021 | Index Vent... | indexventu... |
- | Pentech Ve... | pentech.vc |
- | Emerge Edu... | emerge.edu... |
Funding Rounds 4
Date | Series | Amount | Investors |
13.07.2023 | Series B | $60M | - |
20.05.2021 | Series A | $17M | - |
20.11.2019 | Series A | $5M | Pentech Ve... |
26.07.2018 | Seed | $1M | - |
Mentions in press and media 22
Date | Title | Description | Source |
18.12.2023 | The Largest Funding Rounds for Central and Eastern Europe in... | Bulgaria, Czech Republic, Greece, Poland, Romania ~ Company: As the CEE region continues to establ... | therecursi... |
22.08.2023 | Genesis Therapeutics Rakes In $200M For AI-Powered Drug Disc... | Several startups focused on AI-powered drug discovery have closed multi-million-dollar funding round... | medcitynew... |
31.07.2023 | 4 Ways Biopharma Is Applying AI/ML to Improve Drug Developme... | Healthcare innovation in drug development intersects with a few critical trends: the rise of artific... | medcitynew... |
13.07.2023 | Causaly, an AI platform for drug discovery and biomedical re... | Artificial intelligence has been a big theme in the world of health and medical research, and specif... | techcrunch... |
13.07.2023 | Helping scientists untangle the yarn that is disease biology... | London’s AI/machine learning platform that puts all the preclinical discovery pieces together in a h... | tech.eu/20... |
13.07.2023 | Causaly raises $60M to fuel generative AI-powered drug disco... | Head over to our on-demand library to view sessions from VB Transform 2023. Register Here Causaly, ... | venturebea... |
13.07.2023 | Causaly Secures $60M to Accelerate AI-Powered Biomedical Res... | What You Should Know: Causaly, the leading AI platform for biomedical research raises $60M in Serie... | hitconsult... |
13.07.2023 | Causaly Raises $60M in Series B Funding | Causaly, a London, UK- and Athens, Greece-based provider of an AI platform for biomedical research, ... | finsmes.co... |
13.07.2023 | Using AI for drug development, Causaly raises $60M | The company has now raised $93M in total Developing a new drug is a long process, typically taking ... | vator.tv/n... |
13.07.2023 | Causaly scores $60M to enhance AI platform for biomedical re... | Photo: poba/Getty Images Causaly, a tech company using AI to interpret large datasets and literatur... | mobihealth... |
Show more